The global Cell & Gene Therapy Manufacturing Services Market was valued at USD 11.4 billion in 2023 and is projected to reach USD 70.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.4% over the forecast period from 2024 to 2032. The rising demand for cell and gene therapies, coupled with the increasing trend of outsourcing manufacturing services, is expected to drive significant growth in this market.
Market Overview
Cell and gene therapies represent a rapidly growing sector of the biopharmaceutical industry, offering groundbreaking treatments for a variety of genetic and chronic diseases. These therapies are highly complex and require specialized manufacturing processes. With many companies opting to outsource manufacturing to contract development and manufacturing organizations (CDMOs), the market for cell and gene therapy manufacturing services is expanding rapidly.
Get A Free Sample Report on Cell & Gene Therapy Manufacturing Services Market @ https://www.snsinsider.com/sample-request/ 1187
Key Market Drivers
Rising Demand for Advanced Therapies: The growing focus on cell and gene therapies to treat conditions such as cancer, genetic disorders, and autoimmune diseases is a major driver for the market. With numerous therapies in development and clinical trials, the demand for efficient and scalable manufacturing services is expected to grow.
Outsourcing Manufacturing to CDMOs: Given the complexity of manufacturing cell and gene therapies, many biopharmaceutical companies are choosing to outsource production to specialized CDMOs. Outsourcing provides companies with access to advanced manufacturing capabilities without the need for heavy capital investments, accelerating time-to-market.
Technological Advancements in Manufacturing Processes: Continuous innovations in bioprocessing and manufacturing technologies, including automation and scalable production platforms, are driving improvements in the production of cell and gene therapies. These advancements are expected to increase the efficiency and scalability of manufacturing services.
Regulatory Support and Approvals: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are providing accelerated approval pathways for cell and gene therapies, encouraging the development of more advanced therapeutic solutions and fueling the demand for specialized manufacturing services.
Key Segments:
By Therapy Type
Cell therapy manufacturing
Stem cell therapy
Non stem cell therapy
Gene therapy manufacturing
By Manufacturing Scale
Pre-commercial/R&D scale manufacturing
Commercial scale manufacturing
By Manufacturing Mode
Contract Manufacturing
In-house manufacturing
By Workflow
Cell processing
Cell banking
Process development
Fill & finish operations
Analytical and quality testing
Raw material testing
Vector production
Others
Key Players
Cellular Therapeutics
Lonza
Bluebird Bio Inc.
Thermo Fisher Scientific
Samsung Biologics
Boehringer Ingelheim
Hitachi Chemical Co., Ltd.
Takara Bio Inc.
Catalent Inc.
Miltenyi Biotec
F. Hoffmann-La Roche Ltd
Novartis AG
Merck KGaA
- Wuxi Advanced Therapies and others.
Conclusion
The cell and gene therapy manufacturing services market is expected to experience exponential growth, driven by the increasing adoption of advanced therapies, outsourcing trends, and ongoing technological advancements. As the demand for specialized manufacturing services continues to rise, the market offers lucrative opportunities for industry players in the coming yearS
Make an inquiry on the Cell & Gene Therapy Manufacturing Services Market Report @ https://www.snsinsider.com/enquiry/ 1187
TABLE OF CONTENT
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Therapy Type
8. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Manufacturing Scale
9. Cell & Gene Therapy Manufacturing Services Market Segmentation, by Manufacturing Mode
10. Cell & Gene Therapy Manufacturing Services Market Segmentation, By Workflow
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion
Buy a Single-User PDF of Cell & Gene Therapy Manufacturing Services Market @ https://www.snsinsider.com/checkout/ 1187
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
